Subclavian vein catheterization beats jugular, femoral placement

Subclavian vein catheterization beats jugular, femoral placement

(HealthDay)—For patients in intensive care units who need a catheter, placement in the subclavian vein appears to lower the risk of bloodstream infection and deep-vein thrombosis, compared to jugular or femoral placement, a new study finds. The report was published in the Sept. 24 issue of the New England Journal of Medicine.

For the study, researchers randomly assigned 3,027 patients to have catheters placed in one of three locations: nontunneled central venous catheterization to the subclavian, jugular, or femoral vein. The primary outcome measure was a composite of catheter-related and symptomatic deep-vein thrombosis.

The researchers found subclavian-vein catheterization was associated with a lower risk of bloodstream infection and symptomatic thrombosis than jugular or femoral-vein catheterization. However, subclavian-vein was also associated with a higher risk of pneumothorax.

Lead researcher Jean-Jacques Parienti, M.D., Ph.D., from the department of biostatistics and clinical research at Cote de Nacre University Hospital in Caen France, told HealthDay that "the subclavian route is the safest for the patient, provided that everything is done to reduce the risk of mechanical complications during insertion."

Explore further

Needle guide improves catheterization of subclavian vein

More information: Full Text (subscription or payment may be required)
Journal information: New England Journal of Medicine

Copyright © 2015 HealthDay. All rights reserved.

Citation: Subclavian vein catheterization beats jugular, femoral placement (2015, September 25) retrieved 11 November 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments